LakeShore Biopharma Co., Ltd Ordinary Shares
Symbol: LSB (NASDAQ)
0.85
▲ (1.92%) 0.016
Company Description:
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.
Key Stats
- Today's Open: $0.8363
- Today's High: $0.853
- Today's Low: $0.76
- Today's Volume: 6.77K
- Yesterday Close: $0.834
- Yesterday High: $0.8784
- Yesterday Low: $0.806001
- Yesterday Volume: 135.37K
- Last Min Volume: 53
- Last Min High: $0.85
- Last Min Low: $0.85
- Last Min VWAP: $0.85
Company Profile
- Name: LakeShore Biopharma Co., Ltd Ordinary Shares
- Website: https://www.lakeshorebio.com
- Listed Date: 2023-03-17
- Location: ,
- Market Status: Active
- CIK Number: 0001946399
- SIC Code:
- SIC description:
- Market Cap: $34.37M
- Round Lot: 100
- Outstanding Shares: 41.21M
- Asset Type: CS
RECENT FILINGS FOR LSB
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-10 | 6-K | View |
| 2025-08-28 | 6-K | View |
| 2025-08-27 | SCHEDULE 13D/A | View |
| 2025-08-18 | 6-K | View |
| 2025-07-31 | 6-K | View |
| 2025-07-31 | 20-F | View |
| 2025-07-22 | SCHEDULE 13D | View |
| 2025-07-15 | SCHEDULE 13D/A | View |
| 2025-07-15 | 6-K | View |
| 2025-07-08 | 6-K | View |
| 2025-05-12 | 6-K | View |
| 2025-05-06 | 6-K | View |
| 2025-03-25 | 6-K | View |
| 2025-03-14 | S-8 POS | View |
| 2025-03-12 | 6-K | View |
| 2024-12-19 | 6-K | View |
| 2024-12-12 | 6-K | View |
| 2024-11-12 | 6-K | View |
| 2024-11-07 | 6-K | View |
| 2024-11-01 | 6-K | View |
Latest News on LSB